Experts Implore Seafood Industry to Start Looking Beyond 100 Percent Utilization Into Total Biomass Optimization

Why It Matters

Optimizing total biomass turns waste into profit, enhancing sustainability and cushioning the seafood sector against tightening margins and regulatory pressure.

Key Takeaways

• 30‑50% of harvested fish biomass discarded during primary processing.
• Shrimp heads and shells hold proteins, oils, and chitin for high‑value products.
• Chitosan can fetch $20‑30/kg industrially, up to $40,000/kg medically.
• Grupo Veraz plans a hydrolyzed fishmeal plant serving a 250 km radius.
• Investors view side streams as strategic assets for pharma and nutraceutical markets.

Pulse Analysis

The seafood industry faces mounting pressure as raw material supplies tighten and sustainability expectations rise. Recent estimates indicate that up to half of harvested fish and shrimp are discarded at the first processing stage, representing a massive inefficiency. By reframing these side streams as untapped resources rather than waste, companies can address both environmental concerns and cost structures, aligning with broader circular‑economy trends that investors increasingly reward.

Biotechnological advances are unlocking new pathways to extract high‑value compounds from what was once considered refuse. Shrimp heads and shells, for example, are rich in digestible proteins, omega‑rich oils, and chitin, which can be transformed into chitosan—a biopolymer commanding prices from $20‑30 per kilogram for industrial wastewater treatment to $30,000‑40,000 per kilogram in specialized medical adhesives. Firms like ChitoLytic are scaling these conversions, while the broader market now recognizes over 400 applications for chitosan, spanning food, agriculture, and healthcare.

From an investment perspective, side‑stream valorisation is evolving into a strategic growth engine. Grupo Veraz’s planned hydrolyzed fishmeal facility aims to serve processors within a 250‑kilometer radius, creating a regional hub for protein concentrates and fish oil. Such infrastructure not only improves margins for individual processors but also fuels downstream sectors such as nutraceuticals and pharmaceuticals, where ocean‑derived, traceable ingredients are in high demand. Success hinges on early customer engagement, robust scientific validation, and scalable processing—steps that turn speculative projects into commercially viable opportunities.